COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN THE CZECH NATIONAL IMMUNIZATION PROGRAM

被引：0
|
作者：
Tichopad, A. [1 ]
Vitova, V. [1 ]
Roberts, C. S. [2 ]
Hajek, P. [3 ]
机构：
[1] CEEOR Sro, Prague, Czech Republic
[2] Pfizer, New York, NY USA
[3] Pfizer, Prague, Czech Republic
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.178
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A352 / A353
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN CROATIA NATIONAL VACCINATION PROGRAM
    Tichopad, A.
    Pecen, L.
    Roberts, C. S.
    Uglesic, L.
    Tesovic, G.
    Rogier, K.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A608 - A608
  • [2] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
  • [3] COST-EFFECTIVENESS OF SWITCHING FROM THE 10-VALENT TO THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN SWEDEN
    Wasserman, M.
    Dorange, A. C.
    Palmborg, A.
    McDade, C.
    Wilson, M.
    Horn, E.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S110 - S110
  • [4] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV) Versus 10-Valent PCVs in Filipino Infants
    Perdrizet, J.
    Horn, E.
    Nua, W.
    Perez Peralta, J.
    Nailes, J.
    Santos, J.
    Ong-Lim, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S118 - S118
  • [5] Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
    Sarah J. Pugh
    Mark A. Fletcher
    Apostolos Charos
    Lynda Imekraz
    Matt Wasserman
    Raymond Farkouh
    [J]. Infectious Diseases and Therapy, 2019, 8 : 63 - 74
  • [6] Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10-or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
    Pugh, Sarah J.
    Fletcher, Mark A.
    Charos, Apostolos
    Imekraz, Lynda
    Wasserman, Matt
    Farkouh, Raymond
    [J]. INFECTIOUS DISEASES AND THERAPY, 2019, 8 (01) : 63 - 74
  • [7] COST-EFFECTIVENESS OF INFANT VACCINATION WITH 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUVATE VACCINE IN KOREA
    Lee, J. Y.
    Park, D. J.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A805 - A806
  • [8] Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China
    Shen, Kunling
    Wasserman, Matthew
    Liu, Dongdong
    Yang, Yong-Hong
    Yang, Junfeng
    Guzauskas, Greg F.
    Wang, Bruce C. M.
    Hilton, Betsy
    Farkouh, Raymond
    [J]. PLOS ONE, 2018, 13 (07):
  • [9] COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA
    Whillans, F.
    Kwan, H.
    Strutton, D. R.
    Earnshaw, S. R.
    Farkouh, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
  • [10] Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context
    Bolanos-Diaz, Rafael
    Mino-Leon, Greta
    Zea, Eduardo
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2022, 13 (04) : 341 - 350
12345